ALAB — Astera Labs Cashflow Statement
0.000.00%
- $10.72bn
- $9.81bn
- $396.29m
Annual cashflow statement for Astera Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Net Income/Starting Line | -58.3 | -26.3 | -83.4 |
Depreciation | |||
Non-Cash Items | 31.6 | 21.4 | 230 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -9.97 | -9.68 | -13.3 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Cash from Operating Activities | -35.9 | -12.7 | 137 |
Capital Expenditures | -3.87 | -2.76 | -34.2 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | -86.7 | -15 | -723 |
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | -90.6 | -17.8 | -758 |
Financing Cash Flow Items | 0 | -1.41 | -24.9 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Cash from Financing Activities | 152 | -0.502 | 656 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 25.2 | -31 | 34.9 |